Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion type Assertion NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_head.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion description "[These data support a role for PI3K-AKT pathway activation in kidney tumor formation caused by loss of BHD and suggest that inhibitors of both mTORC1 and mTORC2 may be effective as potential therapeutic agents for BHD-associated kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion evidence source_evidence_literature NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion SIO_000772 19850877 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion wasDerivedFrom befree-2016 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.
- NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_assertion wasGeneratedBy ECO_0000203 NP771187.RABi8ZgAbDX7tks1plX4k0U7VVUctH6F7Fx3bjBfCBEMM130_provenance.